Cited by 38Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingAmyotrophic Lateral Sclerosis Research

Tau proteinopathies and the prion concept

Michel Goedert·2020·Progress in Molecular Biology and Translational Science

Abstract

The ordered assembly of a small number of proteins into amyloid filaments is central to age-related neurodegenerative diseases. Tau is the most commonly affected of these proteins. In sporadic diseases, assemblies of tau form in a stochastic manner in certain brain regions, from where they appear to spread in a deterministic way, giving rise to disease symptoms. Over the past decade, multiple lines of evidence have shown that assembled tau behaves like a prion. More recently, electron cryo-microscopy of tau filaments has shown that distinct conformers are present in different diseases, with no inter-individual variation for a given disease.

Integrity signals

Registry

Crossref · 10.1016/bs.pmbts.2020.08.003

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Short fibrils and oligomers of tau can transfer from one neuron to another and spread pathology throughout the brain in a prion-like manner.

    “Over the past several years, it has become increasingly evident that short fibrils and oligomers of tau can transfer from one neuron to another and thereby spread pathology throughout the brain in a prion-like manner (4, 5, 6).”

    From MAP2 caps tau fibrils and inhibits aggregation (2023) · cites this paper as [5]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goedert, M.
Affiliations
MRC Laboratory of Molecular Biology (GB)
Corresponding author
Michel Goedert
Venue
Progress in Molecular Biology and Translational Science
Publisher
Elsevier
Published
2020
Volume
175
Pages
239-259
ISSN
1877-1173 (ISSN-L)
OpenAlex
W3084416161
Cited by
38
References
21
Citations by year
2026: 3 · 2025: 8 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 7
FWCI
23.76
Type
book chapter
Language
en
Open access
closed
Locations
  • Progress in molecular biology and translational science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
tau protein, prion-like behavior, neurodegenerative diseases, tau filaments, disease spread
MeSH terms
Amino Acid Sequence, Animals, Brain, Humans, Phenotype, Prions, tau Proteins, Neurodegenerative Diseases, Tauopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review